6th Annual Advances in Prenatal Molecular Diagnostic
-第6届产前分子诊断先进技术学会-
日期:2018年10月29-30日
地点:美国马萨诸塞州剑桥,Hyatt Regency Cambridge

请参考暂定版议程

Cell-free DNA筛选及富潜力的细胞基础DNA检测的出现,持续为产前诊断领域带来革命性变化。然而Cell-free DNA检测在临床中越来越被广泛使用、细胞基础DNA检测脚步也紧跟在后,若要完全取代侵入性检测,需要高灵敏度及特异度、以及对临床医师及病患的教育。除此之外,胎儿全基因体定序领域也累积了许多研究成果,在流产检测中发挥重要作用。早产及子痫前症的生物标记检测也在产前照护中扮演重要角色。透过这些检测及筛选获得了比以往更多的信息,检测开发人员、临床医师、遗传谘询师需要掌握这些变化、细微差异、指南的最新信息,以有效提供病患医疗。本届学会除了r介绍最新研究成果之外,也将针对临床实用化及该领域未来方向等进行讨论。

CLINICAL CONSIDERATIONS FOR NIPT

Two Years Later: The Implementation of ACMG's NIPS Practice Guidelines

Brian Skotko, MD, MPP, Co-Director, Down Syndrome Program, Massachusetts General Hospital

Patient Advocacy Groups and Commercial Companies: An Examination

Stephanie Meredith, Program Director, Medical Outreach/Lettercase Program, University of Kentucky

CELL-FREE DNA SCREENING

The VALUE Study: A Novel cfDNA Non-NGS Method to Identify Common Autosomal Trisomies

Glenn Palomaki, PhD, Professor, Department of Pathology and Laboratory Medicine, Women & Infants Hospital and the Alpert Medical School at Brown University

Clinical Relevance: Non-Invasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia

Maria New, MD, Director of Adrenal Steroid Disorders Program, Professor of Pediatrics and Genetics, Pediatric Endocrinology, Icahn School of Medicine at Mount Sinai Hospital

What Role Could NIPT Play in Management of Recurrent Pregnancy Losses (RPL)?

Joe Leigh Simpson, MD, President for Research and Global Programs, March of Dimes Foundation

TOWARDS CELL-BASED NON-INVASIVE PRENATAL DIAGNOSIS

Technical Insights into Next Generation Sequencing Analysis of DNA from Circulating Trophoblastic Cells

Patrizia Paterlini-Brechot, PhD, MD, Cellular & Molecular Biology, University Paris Descartes

Imprinted NanoVelcro Microchips for Isolation and Characterization of Circulating Fetal Trophoblasts – Toward Noninvasive Prenatal Diagnostics

Hsian-Rong Tseng, PhD, Professor, Molecular & Medical Pharmacology, University of California, Los Angeles

Fetal Cells in Maternal Blood for Prenatal Diagnosis – From R&D to Clinic

Ripudaman Singh, PhD, COO, ARCEDI Biotech Aps, Denmark

FETAL WHOLE EXOME SEQUENCING

The Promise of Whole Exome Sequencing

Ronald Wapner, MD, Director, Reproductive Genetics and Vice Chair, Research, Department of Obstetrics & Gynecology, Columbia University Medical Center

Prenatal Whole Exome Sequencing: New Opportunities and Challenges

Neeta Vora, MD, Associate Professor, Department of OB GYN, Division of Maternal-Fetal Medicine, University of North Carolina Chapel Hill

BIOMARKERS FOR PREECLAMPSIA AND PRETERM BIRTH

Prematurity Prevention: New Insights from the Maternal Genome

Louis J. Muglia, MD, PhD, Director, Division of Human Genetics, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati Children’s Hospital Medical Center

Risk Stratification in Pregnancy: The Potential of Extracellular Vesicle Protein Biomarkers in Prenatal Care

Thomas F. McElrath, PhD, Attending in Maternal-Fetal Medicine, Obstetrics and Gynecology, Brigham & Women’s Hospital


* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English





免费电子邮件通知服务